Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Raymond J. Kelleher currently holds 31,675 shares of BridgeBio Oncology Therapeutics, Inc. (BBOT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Raymond J. Kelleher has been a net neutral trader of BBOT stock. They have purchased $0 and sold $0 worth of shares.
Raymond J. Kelleher's most recent insider trade was on Jun 16, 2026, when they sold 31,675 shares at $0.00 per share.
Raymond J. Kelleher serves as Executive at BridgeBio Oncology Therapeutics, Inc. (BBOT). They have executed 1 insider transactions totaling $0 over their tenure at the company.
Raymond J. Kelleher holds the position of Executive at BridgeBio Oncology Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Raymond J. Kelleher has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Raymond J. Kelleher was on Jun 16, 2026, when they purchased $0 worth of BBOT shares. This transaction involved 31,675 shares at N/A per share.
Raymond J. Kelleher currently owns 31,675 shares of BridgeBio Oncology Therapeutics, Inc. (BBOT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Raymond J. Kelleher's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Raymond J. Kelleher has 1 Form 4 filings on record as an insider at BridgeBio Oncology Therapeutics, Inc..
Set alerts for Raymond J. Kelleher and 40,000+ other insiders.